TMDX
TransMedics Group, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$86.42
−0.28%Next report
Analyst consensus
- Next report date
- Nov 4, 2026
- EPS estimate
- $0.27
- Revenue estimate
- $177.0M
Latest reported
- Last report date
- Aug 4, 2026
- EPS actual
- $0.44
- EPS estimate
- $0.50
- Revenue actual
- $189.9M
- Revenue estimate
- $184.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 9
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +13.6%
- Revenue beats (12Q)
- 8
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $103
- PT range
- $77 – $124
- Analysts
- 6
5 Buy1 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 4, 2026 | $0.50 | $0.44 | Miss -11.20% | $189.9M |
| May 5, 2026 | $0.62 | $0.30 | Miss -51.61% | $173.9M |
| Feb 24, 2026 | $0.41 | $0.57 | Beat 39.02% | $160.8M |
| Oct 29, 2025 | $0.37 | $0.66 | Beat 78.38% | $143.8M |
| Jul 30, 2025 | $0.48 | $0.92 | Beat 91.67% | $157.4M |
| May 8, 2025 | $0.29 | $0.70 | Beat 141.38% | $143.5M |
| Feb 27, 2025 | $0.22 | $0.19 | Miss -13.64% | $121.6M |
| Jul 31, 2024 | $0.21 | $0.35 | Beat 66.67% | $114.3M |
| Aug 3, 2023 | -$0.15 | -$0.03 | Beat 80.00% | $52.5M |
| May 1, 2023 | -$0.25 | -$0.08 | Beat 68.00% | $41.6M |
| Feb 22, 2023 | -$0.28 | -$0.21 | Beat 25.00% | $31.4M |
| Nov 3, 2022 | -$0.40 | -$0.25 | Beat 37.50% | $25.7M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026